Furaltadone
Drug profile
Also known as: furaltadon, furaltadone HCl, furaltadone hydrochloride, furantoina, furazolin, furazoline, furmethanol, furmethonol, furmetonol, medifuran, nitraldone, nitrofurmethone
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Furaltadone is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including MAPK9.
- Molecular targets: MAPK9 (1 listed in DrugCentral).
- Molecular formula: C13H16N4O6; molecular weight 324.29 g/mol.
Mechanism & targets
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Mitogen-activated protein kinase 9 | MAPK9 | unknown | IC50 4.87 |
Chemical structure
| Molecular formula | C13H16N4O6 |
|---|---|
| Molecular weight | 324.29 g/mol |
| CAS number | 139-91-3 |
| InChIKey | YVQVOQKFMFRVGR-VGOFMYFVSA-N |
| PubChem CID | 9553856 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Furaltadone work?
Its molecular targets in DrugCentral include MAPK9.
What is the chemical formula of Furaltadone?
Furaltadone has the molecular formula C13H16N4O6 and a molecular weight of 324.29 g/mol.
Browse: all drugs starting with F · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1256 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1189513 — compound record and bioactivity
- PubChem CID 9553856 — chemical identifiers
- DrugBank DB16567 — drug record
- FDA UNII 5X4V82ZN30 — substance identity
- UniProt P45984 (MAPK9) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.